Skip to main content
. 2010 May 23;2010:798467. doi: 10.1155/2010/798467

Figure 3.

Figure 3

CTX influences lymphocyte subsets in peripheral blood and draining lymph nodes of tumor-bearing mice. (a) The percentage of CD19+ cells was significantly decreased (P < .05) in CTX-treated tumor-bearing mice. CD3+ cells were significantly increased (P = .0325) in the peripheral blood of CTX-treated tumor-bearing mice compared to untreated tumor-bearing mice. (b) CD19+ cells were significantly decreased (P < .05) while CD3+ cells were significantly increased (P < .05), while the percentage of CD4+CD25+Foxp3+ cells was significantly decreased (P < .05) in the splenocytes of CTX-treated mice compared to untreated tumor-bearing mice.